Harbor Investment Advisory, LLC Alzamend Neuro, Inc. Transaction History

Harbor Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	BUY	$0.37 - $0.71 $814 - $1,562	2,200 Added 275.0%	3,000 $1,000
Q4 2022 Jan 24, 2023	SELL	$0.53 - $222.0 $484 - $203,130	-915 Reduced 53.35%	800 $0
Q1 2022 Apr 20, 2022	BUY	$0.91 - $2.23 $273 - $669	300 Added 21.2%	1,715 $2,000
Q4 2021 Jan 10, 2022	BUY	$1.9 - $3.08 $1,140 - $1,848	600 Added 73.62%	1,415 $3,000
Q3 2021 Oct 12, 2021	BUY	$2.28 - $7.68 $1,858 - $6,259	815 New	815 $3,000

Ticker ALZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,481,800
Market Cap $115M
Description
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.